Abstract
The p53 tumour suppressor gene is inactivated in various types of human cancers, and has been implicated as an early event in several cancers. A p53 Pro/Arg polymorphism at exon 4 codon 72, has been suggested to be involved in susceptibility to cancers as well. Hence, in the current study, we investigated p53 exon 4 codon 72 polymorphism using Proline or Arginine specific primers from the peripheral blood cells (PBC) representing constitutional DNA from 72 oral cancer patients. PBC from 153 normal healthy individuals were used to determine the frequency of the p53 genotypes, Pro/Pro, Arg/Arg and Pro/Arg, in the Indian population. The frequency of distribution of genotypes in the normal healthy individuals was, Pro/Pro – 0.20 (31/153), Arg/Arg – 0.14 (22/153) and Pro/Arg – 0.65 (100/153); and in the oral cancer patients was, Pro/Pro – 0.19 (14/72), Arg/Arg – 0.08 (6/72) and Pro/Arg – 0.72 (52/72). Thus, we observed an equidistribution of the genotypes in normal control and oral cancer patients (χ2= 1.77, df = 2, 0.3 <P< 0.5). Further, DNA from corresponding tumours from the 72 oral cancer patients were examined for loss of heterozygosity in the p53 gene. Allelic loss was observed in 8 of 52 (15%) heterozygous informative oral cancer patients. Our data indicates an equidistribution of the genotypes and absence of over-representation of either Pro/Pro or Arg/Arg genotypes in the oral cancer patients as compared to the normal healthy controls. Hence, association of the p53 genotypes with susceptibility to oral cancer, was not observed. © 2001 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Choi SY and Kahyo H (1991) Effect of cigarette smoking and alcohol consumption in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Epidemiol 20: 878–885
D’Costa JD, Saranath D, Dedhia P, Sanghavi V and Mehta AR (1998) Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 34: 413–420
Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV and Sidransky D (2000) Evidence for a casual association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709–720
Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Mehta FS and Pindborg JJ (1989) An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer 63: 2247–2252
Hamel N, Black MJ, Ghadirian P and Foulkes WD (2000) No association between p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck. Br J Cancer 82: 757–759
Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, Honn SE and Spitz MR (1995) Higher lung cancer risk for African-Americans with the Pro/Pro p53 genotype. Carcinogenesis 16: 2205–2208
Johnson NW (1991) A global view of the epidemiology of oral cancer. Johnson NWOral cancer detection of patients and lesions at risk 2: pp. 3–26, Cambridge University Press: Cambridge
Johnson NW and Warnakulasuriya KAAS (1993) Epidemiology and aetiology of oral cancer in the United Kingdom. Community Dental Health 10: 13–29
Kawajiri K, Nakachi K, Imai K, Watanabe J and Hayashi S (1993) Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14: 1085–1089
Largey JS, Meltzer SJ, Yin J, Norris K, Sauk JJ and Archibald DW (1993) Loss of heterozygosity of p53 in oral cancers demonstrated by the polymerase chain reaction. Cancer 71: 1933–1937
Mahale A and Saranath D (2000) Microsatellite alterations on chromosome 9 in chewing-tobacco induced oral squamous cell carcinomas from India. Oral Oncol 36: 199–206
Murata M, Tagawa M, Kimura M, Kimura E, Watanabe S and Saisho H (1996) Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis 17: 261–264
Notani PN (2000) Epidemiology and prevention of head and neck cancer: A global view. Saranath DContemporary Issues In Oral Cancer, pp. 1–29, Oxford University Press: New Delhi
Raybaud-Diogene H, Tetu B, Morency R, Fortin A and Monteil RA (1996) p53 overexpression in head and neck squamous cell carcinoma: review of the literature. Oral Oncol Eur J Cancer 32B: 143–149
Saranath D (2000) Integrated biology and molecular pathology of oral cancer. Saranath DContemporary Issues in Oral Cancer, pp. 30–71, Oxford University Press: New Delhi
Saranath D, Panchal R, Nair R, Mehta A, Sanghavi V, Sumegi J, Klein G and Deo M (1989) Oncogene amplification in squamous cell carcinoma of the oral cavity. Jpn J Cancer Res 80: 430–437
Saranath D, Bhoite LT and Deo MG (1993) Molecular lesions in human oral cancer: the Indian scene. Oral Oncol Eur J Cancer 29B: 107–112
Saranath D, Tandle AT and Deo MG (1997) Loss of p53 gene as a biomarker of high risk oral leukoplakias. Ind J Biochem Biophys 34: 266–273
Saranath D, Tandle AT, Teni TR, Dedhia PM, Borges AM, Parikh D, Shanghavi V and Mehta AR (1999) p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India. Oral Oncol 35: 242–250
Sjalander A, Birgander R, Athlin L, Stenling R, Rutegard J, Beckman L and Beckman G (1995) p53 germ line haplotypes associated with increased risk for colorectal cancer. Carcinogenesis 16: 1461–1464
Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G and Banks L (1998) Role of p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229–234
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Tandle, A., Sanghvi, V. & Saranath, D. Determination of p53 genotypes in oral cancer patients from India. Br J Cancer 84, 739–742 (2001). https://doi.org/10.1054/bjoc.2000.1674
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2000.1674
Keywords
This article is cited by
-
Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis
BMC Oral Health (2018)
-
Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis
Cancer Cell International (2014)
-
Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis
BMC Cancer (2014)
-
No evidence of correlation between p53 codon 72 G > C gene polymorphism and cancer risk in Indian population: a meta-analysis
Tumor Biology (2014)
-
No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer
Tumor Biology (2013)
